2,786
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Design and optimization of crocetin loaded PLGA nanoparticles against diabetic nephropathy via suppression of inflammatory biomarkers: a formulation approach to preclinical study

Pages 849-859 | Received 18 May 2019, Accepted 08 Jul 2019, Published online: 14 Sep 2019

References

  • Abo-ouf H, Hooper AWM, White EJ. (2013). Deletion of tumor necrosis factor-α ameliorates neurodegeneration in sandhoff disease mice. Hum Mol Genet 22:3960–75.
  • Ahmed D, Kumar V, Sharma M, Verma A. (2014). Target guided isolation, in-vitro antidiabetic, antioxidant activity and molecular docking studies of some flavonoids from Albizzia Lebbeck Benth. bark. BMC Complement Altern Med 14:155.
  • Amann B, Tinzmann R, Angelkort B. (2003). ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diabetes Care 26:2421.
  • Aveleira A, Lin C, Abcouwer SF, et al. (2010). TNF-ɑ signals through PKC/NF- B to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes 59:2872.
  • Baker RG, Hayden MS, Ghosh S. (2011). NF-kB, inflammation, and metabolic disease. Cell Metab 13:11.
  • Bhatt PC, Verma A, Al AFA, et al. (2017). Development of surface-engineered PLGA nanoparticulate-delivery system of tet1-conjugated nattokinase enzyme for inhibition of Aβ40plaques in Alzheimer’s disease. Int J Nanomedicine 12:8749–68.
  • Bilous R. (2001) Renal structural damage in IDDM and NIDDM – functional relationships. In: Hasslacher C, ed. Diabetic Nephropathy. Willy International: John Wiley & Sons Ltd, 71–89.
  • Bugger H, Abel ED. (2009). Rodent models of diabetic cardiomyopathy. Dis Model Mech 2:454–66.
  • Buraczynska K, Luchowski P, Wojczal J, et al. (2010). Monocyte chemoattractant protein (MCP-1) A-2518G gene polymorphism in stroke patients with different comorbidities. Clin Biochem 43:1421–6.
  • Castro-Perez JM. (2007). Current and future trends in the application of HPLC-MS to metabolite-identification studies. Drug Discov. Today 12:249–56.
  • Cavelti-Weder C, Furrer R, Keller C, et al. (2011). Inhibition of IL-1β improves fatigue in type 2 diabetes. Diabetes Care 34:e158.
  • Chang AS, Hathaway CK, Smithies O, Kakoki M. (2016). Transforming growth factor-β1 and diabetic nephropathy. Am J Physiol Renal Physiol 310:F689–96.
  • Cordonnier D, Maynard C, Pinel N, Halimi S. (2001) Differential diagnosis of proteinuria in diabetic patients. In: Hasslacher C, ed. Diabetic Nephropathy. Singapore: John Wiley & Sons Ltd, 129–143.
  • Dâmaso AR, Duarte FO, Sene-Fiorese M, et al. (2015) Experimental diet models in the investigation of obesity. In: Andersen ML, Tufik S, eds. Rodent Model as Tools in Ethical Biomedical Research. U.K.: Springer International Publishing, 503–16.
  • Giunti S, Barutta F, Perin PC, Gruden G. (2010). Targeting the MCP-1/CCR2 System in diabetic kidney disease. Curr Vasc Pharmacol 8:849–60.
  • Kahles F, Meyer C, Möllmann J, et al. (2014). GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering. Diabetes 63:3221.
  • Kolset SO, Reinholt FP, Jenssen T. (2012). Diabetic nephropathy and extracellular matrix. J Histochem Cytochem 60:976.
  • Kumar V, Ahmed D, Verma A, et al. (2013). Umbelliferone β-D-galactopyranoside from Aegle marmelos (L.) corr. an ethnomedicinal plant with antidiabetic, antihyperlipidemic and antioxidative activity. BMC Complement Altern Med 13:273.
  • Kumar V, Bhatt PC, Kaithwas G, et al. (2016). α-Mangostin mediated pharmacological modulation of hepatic carbohydrate metabolism in diabetes induced Wistar rat. Beni-Suef Univ J Basic Appl Sci 5:255–76.
  • Kumar V, Bhatt PC, Rahman M, et al. (2017). Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies. Int J Nanomedicine 12:6747–58.
  • López-Bojórquez LN, Arechavaleta-Velasco F, Vadillo-Ortega F, et al. (2004). NF-κB translocation and endothelial cell activation is potentiated by macrophage-released signals co-secreted with TNF-α and IL-1β. Inflamm Res 53:567–75.
  • Malik S, Suchal K, Khan SI, et al. (2017). Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways. Am J Physiol - Ren Physiol 313:F414–22.
  • Mark E, Bronwyn D, Gregory J. (2004). Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes. 53:3258–66.
  • Martyn-Nemeth P, Schwarz Farabi S, Mihailescu D, et al. (2016). Fear of hypoglycemia in adults with type 1 diabetes: impact of therapeutic advances and strategies for prevention - A review. J Diabetes Complications 30:167–77.
  • Mason RM, Wahab NA. (2003). Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol 14:1358–73.
  • Moraga AR, Nohales PF, Pérez JA, Gómez-Gómez L. (2004). Glucosylation of the saffron apocarotenoid crocetin by a glucosyltransferase isolated from Crocus sativus stigmas. Planta 219:955.
  • Muñoz-Félix JM, González-Núñez M, López-Novoa JM. (2013). ALK1-Smad1/5 signaling pathway in fibrosis development: friend or foe? Cytokine Growth Factor Rev 24:523–37.
  • Oliveira SHP, Canetti C, Ribeiro RA, Cunha FQ. (2008). Neutrophil migration induced by IL-1β depends upon LTB4 released by macrophages and upon TNF-α and IL-1β released by mast cells. Inflammation 31:36.
  • Piemonti L, Leone BE, Nano R, et al. (2002). Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 51:55–65.
  • Pirooznia N, Hasannia S, Lotfi AS, Ghanei M. (2012). Encapsulation of Alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases. J Nanobiotechnol 10:20.
  • Ramakrishnan P, Clark PM, Mason DE, et al. (2013). Activation of the transcriptional function of the NF-kB protein c-Rel by O-GlcNAc glycosylation. Sci Signal 6:ra75.
  • Reddy MA, Chen Z, Park JT, et al. (2014). Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA. Diabetes 63:4249.
  • Rotter V, Nagaev I, Smith U. (2003). Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in Human fat cells from insulin-resistant subjects. J Biol Chem 278:45777–84.
  • Savioli Lopes M, Jardini AL, Maciel Filho R. (2012). Poly (lactic acid) production for tissue engineering applications. In: Procedia Engineering 42:1402–13.
  • Serasanambati M, Chilakapati SR. (2016). Function of nuclear factor kappa B (NF-kB) in human diseases - a review. South Indian J Biol Sci 2: 368–87.
  • Silva LR, Alves AF, Cavalcante-Silva LHA, et al. (2017). Milonine, a morphinandienone alkaloid, has anti-inflammatory and analgesic effects by inhibiting TNF-α and IL-1β production. Inflammation 40:2074.
  • Sun B, Wang H, Zhang L, et al. (2017). Role of interleukin 17 in TGF-β signaling-mediated renal interstitial fibrosis. Cytokine 106:80–8.
  • Tsai SJ, Huang CS, Mong MC, et al. (2012). Anti-inflammatory and antifibrotic effects of naringenin in diabetic mice. J Agric Food Chem 60:514–21.
  • Tschöp M, Heiman ML. (2001). Rodent obesity models: an overview. Exp. Clin. Endocrinol. Diabetes 109:307–19.
  • Vaishya R, Singh J, Lal H. (2008). Effect of irbesartan on streptozotocin induced diabetic nephropathy: an interventionary study. Indian J Clin Biochem 23:195.
  • Wachlin G, Augstein P, Schröder D, et al. (2003). IL-1β, IFN-γ and TNF-α increase vulnerability of pancreatic beta cells to autoimmune destruction. J Autoimmun 20:303–12.